Sarcoidosis and chronic beryllium disease: Similarities and differences

Seminars in Respiratory and Critical Care Medicine

Volumn 35, Issue 3, 2014, Pages 316-329

  Mayer, Annyce S ^a,b   Hamzeh, Nabeel ^a,c   Maier, Lisa A ^a,b,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b Food Science and Human Nutrition   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

berylliosis; beryllium; chronic beryllium disease; granuloma; lymphocyte proliferation test; occupational disease; sarcoidosis

Indexed keywords

BERYLLIUM;

ARTICLE; BERYLLIOSIS; BRONCHOSCOPY; CLINICAL FEATURE; CONJUNCTIVITIS; CONTACT DERMATITIS; COUGHING; DERMATITIS; DYSPNEA; EMPHYSEMA; ERYTHEMA NODOSUM; FATIGUE; LARYNGOTRACHEOBRONCHITIS; LUNG LAVAGE; OCCUPATIONAL EXPOSURE; PHARYNGITIS; PNEUMOTHORAX; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SARCOIDOSIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; BIOPSY; CELL PROLIFERATION; CHRONIC DISEASE; DRUG EFFECTS; HUMAN; LYMPHOCYTE; PATHOPHYSIOLOGY; PROCEDURES; SARCOIDOSIS, PULMONARY; TOXICITY;

BERYLLIOSIS; BERYLLIUM; BIOPSY; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CELL PROLIFERATION; CHRONIC DISEASE; HUMANS; LYMPHOCYTES; OCCUPATIONAL EXPOSURE; SARCOIDOSIS, PULMONARY;

EID: 84904463625     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0034-1377059     Document Type: Article

References (145)

1. Saltini C., Winestock K., Kirby M., Pinkston P., Crystal R. G. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med: 1989; 320 17 1103 1109 (Pubitemid 19114387)
2. Freiman D. G. Pathologic changes of beryllium disease; discussion of papers by Drs. Hazard and Dudley. AMA Arch Ind Health: 1959; 19 2 188 189
3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med: 1999; 160 2 736 755
4. Thomas P. D., Hunninghake G. W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis: 1987; 135 3 747 760 (Pubitemid 17041617)
5. Hunninghake G. W., Crystal R. G. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med: 1981; 305 8 429 434 (Pubitemid 11047044)
6. Du Bois R. M., Kirby M., Balbi B., Saltini C., Crystal R. G. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis: 1992; 145 5 1205 1211
7. Rossman M. D., Kreider M. E. Is chronic beryllium disease sarcoidosis of known etiology? Sarcoidosis Vasc Diffuse Lung Dis: 2003; 20 2 104 109 (Pubitemid 36841690)
8. Rossman M. D. Chronic beryllium disease: diagnosis and management. Environ Health Perspect: 1996; 104 05 945 947 (Pubitemid 26402335)
9. Williams W. J., Williams W. R. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers. Thorax: 1983; 38 1 41 44 (Pubitemid 13183915)
10. Newman L. S. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect: 1996; 104 05 953 956 (Pubitemid 26402337)
11. Curtis G. H. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol: 1951; 64 4 470 482
12. Müller-Quernheim J., Gaede K. I., Fireman E., Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J: 2006; 27 6 1190 1195 (Pubitemid 44914303)
13. Fireman E., Haimsky E., Noiderfer M., Priel I., Lerman Y. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis: 2003; 20 2 144 148 (Pubitemid 36841696)
14. Newman L. S., Kreiss K. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis: 1992; 145 5 1212 1214
15. Hardy H. L. Differential diagnosis between beryllium poisoning and sarcoidosis. Am Rev Tuberc: 1956; 74 6 885 896
16. Redding R. A., Hardy H. L., Gaensler E. A. Beryllium disease: a 16-year follow-up case study. Respiration: 1968; 25 3 263 278
17. Hardy H. L., Tabershaw I. R. Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J Ind Hyg Toxicol: 1946; 28 197 211
18. Sprince N. L., Kazemi H., Hardy H. L. Current (1975) problem of differentiating between beryllium disease and sarcoidosis. Ann N Y Acad Sci: 1976; 278 654 664
19. Balkissoon R. C., Newman L. S. Beryllium copper alloy (2%) causes chronic beryllium disease. J Occup Environ Med: 1999; 41 4 304 308 (Pubitemid 29190305)
20. Kelleher P. C., Martyny J. W., Mroz M. M., et al. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med: 2001; 43 3 238 249 (Pubitemid 32238503)
21. Maier L. A., Martyny J. W., Liang J., Rossman M. D. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med: 2008; 177 9 1012 1017 (Pubitemid 351717596)
22. Lieben J., Metzner F. Epidemiological findings associated with beryllium extraction. Am Ind Hyg Assoc J: 1959; 20 494 499
23. Williams C. R. Evaluation of exposure data in the beryllium registry; their relation to present maximum allowable concentrations. AMA Arch Ind Health: 1959; 19 2 263 267
24. Hasan F. M., Kazemi H. Chronic beryllium disease: a continuing epidemiologic hazard. Chest: 1974; 65 3 289 293
25. Hardy H. L., Rabe E. W., Lorch S. United States, Beryllium Case Registry (1952-1966). Review of its methods and utility. J Occup Med: 1967; 9 6 271 276
26. Peyton M. F., Worcester J. Exposure data and epidemiology of the beryllium case registry, 1958. AMA Arch Ind Health: 1959; 19 2 94 99
27. Eisenbud M., Lisson J. Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update. J Occup Med: 1983; 25 3 196 202 (Pubitemid 13087575)
28. Cullen M. R., Kominsky J. R., Rossman M. D., et al. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis: 1987; 135 1 201 208 (Pubitemid 17223914)
29. Kreiss K., Newman L. S., Mroz M. M., Campbell P. A. Screening blood test identifies subclinical beryllium disease. J Occup Med: 1989; 31 7 603 608 (Pubitemid 19179743)
30. Henneberger P. K., Goe S. K., Miller W. E., Doney B., Groce D. W. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg: 2004; 1 10 648 659 (Pubitemid 39387567)
31. Van Dyke M. V., Martyny J. W., Mroz M. M., et al. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. Occup Environ Med: 2011; 68 11 842 848
32. Van Dyke M. V., Martyny J. W., Mroz M. M., et al. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med: 2011; 183 12 1680 1688
33. Taiwo O. A., Slade M. D., Cantley L. F., et al. Beryllium sensitization in aluminum smelter workers. J Occup Environ Med: 2008; 50 2 157 162 (Pubitemid 351321683)
34. Schuler C. R., Kitt M. M., Henneberger P. K., Deubner D. C., Kreiss K. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort. J Occup Environ Med: 2008; 50 12 1343 1350
35. Kreiss K., Wasserman S., Mroz M. M., Newman L. S. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med: 1993; 35 3 267 274 (Pubitemid 23084157)
36. Stange A. W., Hilmas D. E., Furman F. J. Possible health risks from low level exposure to beryllium. Toxicology: 1996; 111 1-3 213 224 (Pubitemid 26247046)
37. 3 Am J Ind Med: 1996; 30 1 16 25 (Pubitemid 26279451)
38. Kreiss K., Mroz M. M., Zhen B., Wiedemann H., Barna B. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med: 1997; 54 8 605 612 (Pubitemid 27374989)
39. Newman L. S., Mroz M. M., Maier L. A., Daniloff E. M., Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med: 2001; 43 3 231 237 (Pubitemid 32238502)
40. Henneberger P. K., Cumro D., Deubner D. D., Kent M. S., McCawley M., Kreiss K. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health: 2001; 74 3 167 176 (Pubitemid 32377453)
41. Deubner D. C., Goodman M., Iannuzzi J. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg: 2001; 16 5 521 526 (Pubitemid 32428736)
42. Sackett H. M., Maier L. A., Silveira L. J., et al. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med: 2004; 46 9 953 961 (Pubitemid 39237556)
43. Schuler C. R., Kent M. S., Deubner D. C., et al. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med: 2005; 47 3 195 205 (Pubitemid 40326251)
44. Welch L., Ringen K., Bingham E., et al. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Ind Med: 2004; 46 3 207 218 (Pubitemid 39180816)
45. Rosenman K., Hertzberg V., Rice C., et al. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect: 2005; 113 10 1366 1372 (Pubitemid 41511994)
46. Stange A. W., Hilmas D. E., Furman F. J., Gatliffe T. R. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg: 2001; 16 3 405 417 (Pubitemid 32182987)
47. Kreiss K., Mroz M. M., Zhen B., Martyny J. W., Newman L. S. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis: 1993; 148 4 Pt 1 985 991 (Pubitemid 23301218)
48. Newman L. S., Mroz M. M., Balkissoon R., Maier L. A. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med: 2005; 171 1 54 60 (Pubitemid 40051695)
49. Bailey R. L., Thomas C. A., Deubner D. C., Kent M. S., Kreiss K., Schuler C. R. Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant. J Occup Environ Med: 2010; 52 5 505 512
50. Thomas C. A., Bailey R. L., Kent M. S., Deubner D. C., Kreiss K., Schuler C. R. Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility. Public Health Rep: 2009; 124 01 112 124
51. Eisenbud M. The standard for control of chronic beryllium disease. Appl Occup Environ Hyg: 1998; 13 25 31 (Pubitemid 28119601)
52. Glazer C. S., Rose C. S., Lynch D. A. Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging: 2002; 17 4 261 272
53. Tillie-Leblond I., Grenouillet F., Reboux G., et al. Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J: 2011; 37 3 640 647
54. Marinelli W. A., Davies S. F. Granulomatous diseases of the lung that mimic respiratory infections. Semin Respir Infect: 1988; 3 3 181 202
55. Newman L. S., Rose C. S., Bresnitz E. A., et al. ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med: 2004; 170 12 1324 1330 (Pubitemid 39657197)
56. Prezant D. J., Dhala A., Goldstein A., et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest: 1999; 116 5 1183 1193 (Pubitemid 29535967)
57. Kern D. G., Neill M. A., Wrenn D. S., Varone J. C. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis: 1993; 148 4 Pt 1 974 980 (Pubitemid 23301216)
58. Kucera G. P., Rybicki B. A., Kirkey K. L., et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest: 2003; 123 5 1527 1535 (Pubitemid 36549772)
59. Gorham E. D., Garland C. F., Garland F. C., Kaiser K., Travis W. D., Centeno J. A. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. Chest: 2004; 126 5 1431 1438 (Pubitemid 39525013)
60. Rossman M. D., Thompson B., Frederick M., et al. ACCESS Group. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 2008; 25 2 125 132
61. Barnard J., Rose C., Newman L., et al. ACCESS Research Group. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med: 2005; 47 3 226 234 (Pubitemid 40365760)
62. Hardy H. L. The definition of sarcoidosis. Am Rev Respir Dis: 1961; 84 5 1 5
63. Centers for Disease Control and Prevention (CDC) Sarcoidosis among U.S. Navy enlisted men, 1965-1993. MMWR Morb Mortal Wkly Rep: 1997; 46 23 539 543
64. Rafnsson V., Ingimarsson O., Hjalmarsson I., Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med: 1998; 55 10 657 660 (Pubitemid 28428962)
65. Drent M., Bomans P. H., Van Suylen R. J., Lamers R. J., Bast A., Wouters E. F. Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med: 2000; 94 8 815 820 (Pubitemid 30628244)
66. Bowers B., Hasni S., Gruber B. L. Sarcoidosis in World Trade Center rescue workers presenting with rheumatologic manifestations. J Clin Rheumatol: 2010; 16 1 26 27
67. Izbicki G., Chavko R., Banauch G. I., et al. World Trade Center sarcoid-like granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest: 2007; 131 5 1414 1423 (Pubitemid 46762347)
68. Crowley L. E., Herbert R., Moline J. M., et al. Sarcoid like granulomatous pulmonary disease in World Trade Center disaster responders. Am J Ind Med: 2011; 54 3 175 184
69. Jordan H. T., Stellman S. D., Prezant D., Teirstein A., Osahan S. S., Cone J. E. Sarcoidosis diagnosed after September 11, 2001, among adults exposed to the World Trade Center disaster. J Occup Environ Med: 2011; 53 9 966 974
70. Dourado L., Kawassaki A. M., Baldi B. G., et al. Is silica exposure a precipitating agent of pulmonary sarcoidosis? American Thoracic Society International Conference. New Orleans, LA, 2010
71. Douglas J. G., Middleton W. G., Gaddie J., et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax: 1986; 41 10 787 791
72. Gerke A. K., van Beek E., Hunninghake G. W. Smoking inhibits the frequency of bronchovascular bundle thickening in sarcoidosis. Acad Radiol: 2011; 18 7 885 891
73. Sato H., Silveira L., Fingerlin T., et al. TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol: 2007; 119 3 687 696
74. Yeager H., Gopalan S., Mathew P., Lawless O., Bellanti J. A. Sarcoidosis: can a murine model help define a role for silica? Med Hypotheses: 2012; 78 1 36 38
75. Selman M., Pardo A., King T. E. Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med: 2012; 186 4 314 324
76. Van Ordstrand H. S., Hughes R., Carmody M. G. Chemical pneumonia in workers extracting beryllium oxide: Report of three cases. Cleve Clin Q: 1943; 10 10 18
77. Van Ordstrand H. S., Hughes R., DeNardi J. M., Carmody M. G. Beryllium poisoning. J Am Med Assoc: 1945; 129 1084 1090
78. Denardi J. M., Van Ordstrand H. S., Curtis G. H., Zielinski J. Berylliosis; summary and survey of all clinical types observed in a twelve-year period. AMA Arch Ind Hyg Occup Med: 1953; 8 1 1 24
79. Van Ordstrand H. S. Current concepts of beryllium poisoning. Ann Intern Med: 1951; 35 6 1203 1217
80. Tepper L. B., Hardy H. L., Chamberlin R. I. Toxicity of beryllium compounds. In: Browning E., ed. Elsevier Monographs on Toxic Agents. Amsterdam Elsevier Publishing Company: 1961; 132 145
81. Hardy H. L. Beryllium poisoning-lessons in control of man-made disease. N Engl J Med: 1965; 273 22 1188 1199
82. Van Ordstrand H. S. Diagnosis of beryllium disease. AMA Arch Ind Health: 1959; 19 2 157 159
83. Cummings K. J., Deubner D. C., Day G. A., et al. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med: 2007; 64 2 134 140
84. Keary P. J., Palmer D. G. Benign self-limiting sarcoidosis with skin and joint involvement. N Z Med J: 1976; 83 560 197 199
85. Stoeckle J. D., Hardy H. L., Weber A. L. Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. Am J Med: 1969; 46 4 545 561
86. Tepper L. B. Beryllium. Crit Rev Toxicol: 1972; 1 235 259
87. Freiman D. G., Hardy H. L. Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Pathol: 1970; 1 1 25 44
88. Newman L. S., Kreiss K., King T. E. Jr, Seay S., Campbell P. A. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis: 1989; 139 6 1479 1486 (Pubitemid 19155510)
89. Pappas G. P., Newman L. S. Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis: 1993; 148 3 661 666 (Pubitemid 23263776)
90. Newman L. S. Immunology, genetics, and epidemiology of beryllium disease. Chest: 1996; 109 (3, Suppl): 40S 43S
91. Mroz M. M., Maier L. A., Strand M., Silviera L., Newman L. S. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med: 2009; 52 10 762 773
92. Cullen M. R., Cherniack M. G., Kominsky J. R. Chronic beryllium disease in the United States. Sem Respir Med: 1986; 7 203 209 (Pubitemid 16170721)
93. Andrews J. L., Kazemi H., Hardy H. L. Patterns of lung dysfunction in chronic beryllium disease. Am Rev Respir Dis: 1969; 100 6 791 800
94. Lundgren R. A., Maier L. A., Rose C. S., Balkissoon R. C., Newman L. S. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest: 2001; 120 5 1702 1708 (Pubitemid 33078493)
95. Robert A. G. A consideration of the roentgen diagnosis of chronic pulmonary granulomatosis of beryllium workers. AJR: 1950; 63 467 487
96. Aronchick J. M., Rossman M. D., Miller W. T. Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology: 1987; 163 3 677 682 (Pubitemid 17083228)
97. Kline E. M., Inkley S. R., Pritchard W. H. Five cases from the fluorescent lamp industry; treatment of chronic beryllium poisoning with ACTH and cortisone. AMA Arch Ind Hyg Occup Med: 1951; 3 6 549 564
98. Newman L. S., Buschman D. L., Newell J. D. Jr, Lynch D. A. Beryllium disease: assessment with CT. Radiology: 1994; 190 3 835 840 (Pubitemid 24071056)
99. Daniloff E. M., Lynch D. A., Bartelson B. B., Newell J. D. Jr, Bernstein S. M., Newman L. S. Observer variation and relationship of computed tomography to severity of beryllium disease. Am J Respir Crit Care Med: 1997; 155 6 2047 2056 (Pubitemid 27256137)
100. Sood A., Beckett W. S., Cullen M. R. Variable response to long-term corticosteroid therapy in chronic beryllium disease. Chest: 2004; 126 6 2000 2007 (Pubitemid 39644011)
101. Marchand-Adam S., El Khatib A., Guillon F., et al. Short- and long-term response to corticosteroid therapy in chronic beryllium disease. Eur Respir J: 2008; 32 3 687 693
102. Sprince N. L., Kanarek D. J., Weber A. L., Chamberlin R. I., Kazemi H. Reversible respiratory disease in beryllium workers. Am Rev Respir Dis: 1978; 117 6 1011 1017 (Pubitemid 8380197)
103. Kline E. M., Moir T. W. Long-term experience with beryllium disease; a report of twenty patients. AMA Arch Ind Health: 1959; 19 2 104 109
104. Chesner C. Chronic pulmonary granulomatosis in residents of a community near a beryllium plant; 3 autopsied cases. Ann Intern Med: 1950; 32 6 1028 1048
105. Baughman R. P., Lower E. E. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 2001; 18 1 70 74 (Pubitemid 32280539)
106. Alhamad E. H., Lynch J. P. III, Martinez F. J. Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med: 2001; 22 4 715 750, ix (Pubitemid 34020010)
107. Nishino M., Lee K. S., Itoh H., Hatabu H. The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol: 2010; 73 1 66 73
108. Vilaplana J., Romaguera C., Grimalt F. Occupational and non-occupational allergic contact dermatitis from beryllium. Contact Dermat: 1992; 26 5 295 298
109. Haberman A. L., Pratt M., Storrs F. J. Contact dermatitis from beryllium in dental alloys. Contact Dermat: 1993; 28 3 157 162 (Pubitemid 23093364)
110. Van Ordstrand H. S., Netherton E. W., DeNardi J. M., Carmody M. G. Beryllium skin granulomas from a broken fluorescent tube; report of a case. Cleve Clin Q: 1950; 17 1 47 54, illust
111. DeNardi J. M. Berylliosis (beryllium poisoning). Cur Ther: 1958; 714 717
112. Collin B., Rajaratnam R., Lim R., Lewis H. A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department. Clin Exp Dermatol: 2010; 35 2 131 134
113. Lodha S., Sanchez M., Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest: 2009; 136 2 583 596
114. Rose A. S., Tielker M. A., Knox K. S. Hepatic, ocular, and cutaneous sarcoidosis. Clin Chest Med: 2008; 29 3 509 524, ix (Pubitemid 351778208)
115. Ali M. M., Atwan A. A., Gonzalez M. L. Cutaneous sarcoidosis: updates in the pathogenesis. J Eur Acad Dermatol Venereol: 2010; 24 7 747 755
116. Stange A. W., Furman F. J., Hilmas D. E. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am J Ind Med: 2004; 46 5 453 462 (Pubitemid 39507658)
117. Maier L. A. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg: 2001; 16 5 514 520 (Pubitemid 32428735)
118. Frome E. L., Newman L. S., Cragle D. L., Colyer S. P., Wambach P. F. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology: 2003; 183 1-3 39 56 (Pubitemid 36005388)
119. Middleton D. C., Fink J., Kowalski P. J., Lewin M. D., Sinks T. Optimizing BeLPT criteria for beryllium sensitization. Am J Ind Med: 2008; 51 3 166 172 (Pubitemid 351272940)
120. Siltzbach L. E. The Kveim test in sarcoidosis. A study of 750 patients. JAMA: 1961; 178 476 482
121. Munro C. S., Mitchell D. N. The K veim response: still useful, still a puzzle. Thorax: 1987; 42 5 321 331 (Pubitemid 17070846)
122. Ribeiro M., Fritscher L. G., Al-Musaed A. M., et al. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung: 2011; 189 3 233 241
123. NIOSH Response to Health Hazard Evaluation request by NIOSH from Management of the U.S. G.S.A Bannister Federal Complex in Kansas City, MO. In: Services DoHaH, ed. Vol. HETA 2010-0061: NIOSH, 2011
124. Newman L. S., Mroz M. M., Schumacher B., Daniloff E., Kreiss K. Beryllium sensitization precedes chronic beryllium disease. Am Rev Respir Dis (Suppl): 1992; 145 A324
125. Bill J. R., Mack D. G., Falta M. T., et al. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol: 2005; 175 10 7029 7037 (Pubitemid 41598950)
126. Richeldi L., Sorrentino R., Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science: 1993; 262 5131 242 244 (Pubitemid 23344468)
127. Weston A., Ensey J., Kreiss K., Keshava C., McCanlies E. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease. Am J Ind Med: 2002; 41 6 457 465 (Pubitemid 34595239)
128. Fontenot A. P., Torres M., Marshall W. H., Newman L. S., Kotzin B. L. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A: 2000; 97 23 12717 12722
129. Sawyer R. T., Doherty D. E., Schumacher B. A., Newman L. S. Beryllium-stimulated in vitro migration of peripheral blood lymphocytes. Toxicology: 1999; 138 3 155 163 (Pubitemid 29492917)
130. Fontenot A. P., Falta M. T., Freed B. M., Newman L. S., Kotzin B. L. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol: 1999; 163 2 1019 1026 (Pubitemid 29328115)
131. Rossman M. D., Kern J. A., Elias J. A., et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med: 1988; 108 5 687 693
132. Tinkle S. S., Schwitters P. W., Newman L. S. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Environ Health Perspect: 1996; 104 05 969 971 (Pubitemid 26402339)
133. Fontenot A. P., Canavera S. J., Gharavi L., Newman L. S., Kotzin B. L. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest: 2002; 110 10 1473 1482 (Pubitemid 35396918)
134. Jonth A. C., Silveira L., Fingerlin T. E., et al. ACCESS Group. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol: 2007; 179 6 4255 4262
135. Sato H., Silveira L., Spagnolo P., et al. CC chemokine receptor 5 gene polymorphisms in beryllium disease. Eur Respir J: 2010; 36 2 331 338
136. Bekris L. M., Viernes H. M., Farin F. M., Maier L. A., Kavanagh T. J., Takaro T. K. Chronic beryllium disease and glutathione biosynthesis genes. J Occup Environ Med: 2006; 48 6 599 606 (Pubitemid 43904251)
137. Gerke A. K., Hunninghake G. The immunology of sarcoidosis. Clin Chest Med: 2008; 29 3 379 390, vii (Pubitemid 351778215)
138. Spagnolo P., Grunewald J. Recent advances in the genetics of sarcoidosis. J Med Genet: 2013; 50 5 290 297
139. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med: 2010; 31 4 380 389
140. Spagnolo P., Renzoni E. A., Wells A. U., et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med: 2005; 172 6 721 728 (Pubitemid 41324227)
141. Maier L. A., Barkes B. Q., Mroz M., et al. Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease. Respir Med: 2012; 106 12 1810 1813
142. Paramothayan N. S., Lasserson T. J., Jones P. W. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev: 2005; 2 CD001114
143. Paramothayan S., Lasserson T. J., Walters E. H. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database Syst Rev: 2006; 3 CD003536
144. Baughman R. P., Drent M., Kavuru M., et al. Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med: 2006; 174 7 795 802 (Pubitemid 44511661)
145. Sahoo D. H., Bandyopadhyay D., Xu M., et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J: 2011; 38 5 1145 1150